中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2014年
29期
54-55
,共2页
肺心病%急性加重期%中西医结合
肺心病%急性加重期%中西醫結閤
폐심병%급성가중기%중서의결합
Pulmonary heart disease%Acute exacerbation%The integrative medicine
目的:观察中西医结合治疗肺心病急性加重期45例的临床疗效。方法:90例符合纳入标准的患者随机分为观察组和对照组各45例,两组患者均给予西医的综合对症治疗和常规护理,观察组在此基础上内服中药汤剂治疗,14d后对比两组患者的临床疗效和FIB、HCT、MAP和CO的变化。结果:观察组总有效率达93.3%,高于对照组的84.4%,但差异并无统计学意义(P>0.05);两组患者治疗后FIB、HCT和MAP均有所下降,而CO则明显上升,与治疗前相比差异均具有统计学意义(P<0.05);治疗后两组各指标组间比较,观察组的FIB、HCT和MAP均低于对照组,而CO则高于对照组,差异均具有统计学意义(P<0.05)。结论:中西医结合治疗肺心病急性加重期疗效确切,优于单纯西药治疗。
目的:觀察中西醫結閤治療肺心病急性加重期45例的臨床療效。方法:90例符閤納入標準的患者隨機分為觀察組和對照組各45例,兩組患者均給予西醫的綜閤對癥治療和常規護理,觀察組在此基礎上內服中藥湯劑治療,14d後對比兩組患者的臨床療效和FIB、HCT、MAP和CO的變化。結果:觀察組總有效率達93.3%,高于對照組的84.4%,但差異併無統計學意義(P>0.05);兩組患者治療後FIB、HCT和MAP均有所下降,而CO則明顯上升,與治療前相比差異均具有統計學意義(P<0.05);治療後兩組各指標組間比較,觀察組的FIB、HCT和MAP均低于對照組,而CO則高于對照組,差異均具有統計學意義(P<0.05)。結論:中西醫結閤治療肺心病急性加重期療效確切,優于單純西藥治療。
목적:관찰중서의결합치료폐심병급성가중기45례적림상료효。방법:90례부합납입표준적환자수궤분위관찰조화대조조각45례,량조환자균급여서의적종합대증치료화상규호리,관찰조재차기출상내복중약탕제치료,14d후대비량조환자적림상료효화FIB、HCT、MAP화CO적변화。결과:관찰조총유효솔체93.3%,고우대조조적84.4%,단차이병무통계학의의(P>0.05);량조환자치료후FIB、HCT화MAP균유소하강,이CO칙명현상승,여치료전상비차이균구유통계학의의(P<0.05);치료후량조각지표조간비교,관찰조적FIB、HCT화MAP균저우대조조,이CO칙고우대조조,차이균구유통계학의의(P<0.05)。결론:중서의결합치료폐심병급성가중기료효학절,우우단순서약치료。
Objective:To observe clinical effects of the integrative medicine on 45 cases of acute exacerbation of pulmonary heart disease. Methods:90 patients were randomly divided into the observation group and the control group, 45 cases for each. Two groups were given western medicine treatment and routine care;while the control group was added TCM medicine. With 14 days of treatment, clinical effects and the changes of FIB, HCT, MAP and CO were compared. Results: The efficiency in the observation group (93.3%) was better than (84.4%) in the control group without statistical significance (P>0.05). The level of FIB, HCT, MAP was slower than that before treatment, while the level of CO was higher than before obviously (P<0.05);with treatment, the level of FIB, HCT and MAP was lower than the control, while the level of CO was higher than the control with statistical significance (P<0.05). Conclusion:The efficacy of the integrative medicine therapy on pulmonary heart disease was confirmed, and better than western medicine treatment.